Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
As the International AIDS Conference wrapped up today, international aid agency Oxfam praised the advocates and the scientists who have ignited momentum to shift from “fighting AIDS” to “ending AIDS,” and urged governments and the pharmaceutical industry to make this vision a reality.
Despite commitment to end AIDS, the US government is introducing stronger intellectual property rules through trade agreements and bilateral pressure that will undermine the fight against AIDS by devastating the ability of developing countries to access affordable anti-retroviral medicines.
In the Democratic Republic of Congo, Oxfam's work combines short-term emergency relief with longer-term development projects. These photos show a part of our wide range of activities in eastern DRC, including: livelihoods programs; support for small-scale farmers; water, sanitation and health; and, training for women's committees.
In a report released today, Oxfam urged the Haitian Government and countries that have pledged money for rebuilding to accelerate reconstruction of the country.
The Zambia general elections will be held on 20 September to elect a president and representatives to the National Assembly. Civil society organizations in Zambia have identified the elections as an opportunity to ensure key health issues are a priority during the upcoming elections.
In their Deauville Accountability Report, the G8 has massaged the figures, claiming to have delivered almost US$49 billion of the promised $50 billion. But according to the OECD, responsible for measuring the official aid figures, the G8 have delivered just $31 billion.